SCHEMBL7662096

SCHEMBL7662096

CC(C)CC(N)C(=O)NCCCC(c1ccc(F)cc1)c1ccc(F)cc1

nearest known ligand 0.72

Predicted protein targets (top 15)

geneUniProtsupporting neighboursconfidence
▸ CACNA1B Q00975 2/20 0.72
▸ SLC6A3 Q01959 7/20 0.49
▸ FNTA P49354 1/20 0.42
▸ FNTB P49356 1/20 0.42
▸ PGGT1B P53609 1/20 0.42
▸ CTSL P07711 2/20 0.42
▸ FAAH O00519 1/20 0.42
▸ CYP3A4 P08684 1/20 0.42
▸ CYP2D6 P10635 1/20 0.42
▸ TSHR P16473 1/20 0.42
▸ ALOX12 P18054 1/20 0.42
▸ MAPK1 P28482 1/20 0.42
▸ MTOR P42345 1/20 0.42
▸ RAB9A P51151 1/20 0.42
▸ EPHX2 P34913 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7664030 0.87 CACNA1B (0.67) CACNA1BSLC6A3FAAHCYP3A4CYP2D6
SCHEMBL7668236 0.84 CACNA1B (0.64) CACNA1BSLC6A3FAAHCYP3A4CYP2D6
SCHEMBL25531422 0.84 CACNA1B (1.00) CACNA1BSLC6A3CTSLFAAHCYP3A4
SCHEMBL11932026 0.84 CACNA1B (1.00) CACNA1BSLC6A3CTSLFAAHCYP3A4
SCHEMBL7656059 0.81 CACNA1B (0.60) CACNA1BSLC6A3FAAHCYP3A4CYP2D6
SCHEMBL7390781 0.80 CACNA1B (0.73) CACNA1BSLC6A3FAAHCYP3A4CYP2D6
SCHEMBL7383617 0.80 CACNA1B (0.73) CACNA1BSLC6A3FAAHCYP3A4CYP2D6
SCHEMBL7383612 0.80 CACNA1B (0.73) CACNA1BSLC6A3FAAHCYP3A4CYP2D6
SCHEMBL7666024 0.80 CNR1 (0.60) EPHX2
SCHEMBL7319572 0.80 CNR1 (0.60) EPHX2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6458781-B1 BLOCKERS CALCIUM CHANNEL ANTAGONISTS FOR STROKES, BRAIN DISORDERS WARNER-LAMBERT COMPANY 2002-10-01 — — US claimed
US-6458781-B1 BLOCKERS CALCIUM CHANNEL ANTAGONISTS FOR STROKES, BRAIN DISORDERS WARNER-LAMBERT COMPANY 2002-10-01 — — US disclosed
Send feedback